ArticleBioorganic & medicinal chemistry letters2013

Novel ROS-activated agents utilize a tethered amine to selectively target acute myeloid leukemia.

Tiffany R Bell-Horwath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.